Judge Certifies Pay-For-Delay Insurer Class For Alzheimer’s Drug Namenda, Generics
NEW YORK — A New York federal judge on Feb. 11 granted a motion by a union health benefit fund to certify a class of purchasers of the Alzheimer’s drug Namenda...To view the full article, register now.
Already a subscriber? Click here to view full article